跳至主要内容
临床试验/ACTRN12611000297921
ACTRN12611000297921暂停3 期

A Randomized controlled trial comparing Topical use of Mupirocin versus Medihoney for the prevention of infection at Tenckhoff Exit Site in Peritoneal Dialysis Patients

Department of Renal Medicine0 个研究点目标入组 380 人开始时间: 2011年3月21日最近更新:

试验速览

阶段
3 期
状态
暂停
发起方
入组人数
380

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • 1. Patients on peritoneal dialysis.( Incident and prevalent)
  • 2. Able to give informed consent

排除标准

  • 1. PD patients who had exit site infection, peritonitis, or tunnel infection within the last 4 weeks
  • 2. Known hypersensitivity to, or intolerance of, honey or mupirocin.
  • 3. On long term antibiotics for any reason.
  • 4. Patients with a history of psychological illness or condition which interferes with their ability to understand or comply with the requirements of the study.

研究者

发起方
Department of Renal Medicine

相似试验